The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 12, 2022

Filed:

Jan. 10, 2017
Applicant:

Dr. Reddy's Laboratories Limited, Hyderabad, IN;

Inventors:

Riyaz Ahmed Shaik, Hyderabad, IN;

Ananya Saha, Asansol, IN;

Svb Janardhan Garikipati, Visakhapatnam, IN;

Akash Chaurasiya, Agra, IN;

Bhavesh Vallabhbhai Patel, Hyderabad, IN;

Harshal Bhagwatwar, Hyderabad, IN;

Sumitra Ashok Pillai, Ahmedabad, IN;

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/664 (2006.01); A61K 9/08 (2006.01); A61K 31/675 (2006.01); A61K 9/19 (2006.01); A61K 9/00 (2006.01); A61K 47/10 (2017.01); A61K 47/26 (2006.01); A61K 47/44 (2017.01); B01D 15/08 (2006.01);
U.S. Cl.
CPC ...
A61K 31/664 (2013.01); A61K 9/0019 (2013.01); A61K 9/08 (2013.01); A61K 9/19 (2013.01); A61K 31/675 (2013.01); A61K 47/10 (2013.01); A61K 47/26 (2013.01); A61K 47/44 (2013.01); B01D 15/08 (2013.01);
Abstract

The present invention relates to stable liquid pharmaceutical formulations of cyclophosphamide comprising cyclophosphamide and at least one pharmaceutically acceptable excipient wherein moisture content of the liquid formulation is less than about 2.0% by weight. The invention further relates to stable liquid formulations of cyclophosphamide prepared by a process comprising a step of reducing the moisture content from cyclophosphamide or liquid compositions of cyclophosphamide or both. The invention further relate to method of using such stable liquid formulations of cyclophosphamide for parenteral administration either as ready-to-use or ready-to-dilute for treating various cancer disorders.


Find Patent Forward Citations

Loading…